National Health Mission (NHM), Madhya Pradesh invited applications for recruitment to 04 posts of Consultants. The candidates eligible for the post can apply in the prescribed format on or before 12 June 2017.
Important dates:
Last Date of Application : 12 June 2017
NHM, Madhya Pradesh, Vacancy Details:
- Consultants (Engineer/Drug Cell/ Others): 04 Posts
Eligibility Criteria for, NHM, Madhya Pradesh Posts
Educational/Technical Qualification & Experience:
- Consultants (Bio Medical Engineer): Graduation in BME (only regular degree/courses will be considered) Desirable 1. ME/M.Tech/PhD in Biomedical Engineering, Experience in installation/Maintenance of medical equipment in Govt./PSU/ International multilateral organizations like UNICEF/UNDP/World Bank etc./BSE/ NSE listed companies
- Consultants (Diagnostic Drug Cell): B.Pharm. & MBA – Logistics Management or Procurement Management (only regular degree/courses will be considered) Desirable : M. Pharma. Experience in Procurement/Maintenance of medical equipment in Govt./PSU/ International multilateral organizations like UNICEF/UNDP/World Bank etc/BSE/ NSE listed companies
- Consultants (Drug Cell): B.Pharm. & MBA – Logistics Management or BE/B.Tech in BME & MBA - Logistics
Selection Process for, NHM, Madhya Pradesh Posts
The selections for these posts will be made through interviews and past academic performances.
How to Apply for, NHM, Madhya Pradesh Posts
The candidates are advised to refer to the official notification below and apply as per the prescribed format. The last date to submit duly filled application forms is 12 June 2017. The website http://mpinfo.org can also be referred to for more details regarding the recruitment procedure.
Detailed Notification, NHM, Madhya Pradesh Recruitment 2017
NHM, Madhya Pradesh Recruitment 2017 for 12 Sub Engineer Posts
NHM, Malappuram Recruitment 2017, Apply for 25 Junior Public Health Nurse Posts
Get the latest Sarkari Naukri notification and find study materials, study tips and practice paper sets for Sarkari Naukri exams
Comments
All Comments (0)
Join the conversation